EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress

Zhongli Wang, Jianlong Zhai, Tingting Zhang, Lili He, Sai Ma, Qingjuan Zuo, Guorui Zhang, Yan Wang, Yifang Guo

Biochemical and Biophysical Research Communications · 2023-04 · 653 · 53-61

DOI: 10.1016/j.bbrc.2023.01.084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-04. Verfasst von Zhongli Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; Department of Physical Examination Center, Hebei General Hospi…. Hauptthemen laut MEDLINE: Hypertension, Kidney Diseases, Sirtuin 3. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertensive nephropathy is characterized by long-term damage to renal tissues by chronic uncontrolled hypertension, and ultimately leads to the development of renal fibrosis. The epithelial-mesenchymal transition (EMT) potentially contributes to the promotion of renal fibrosis in chronic kidney disease (CKD). In this study, we investigated the potential roles of canagliflozin (Cana) on renal EMT and oxidative stress through its effects on sirtuin 3 (SIRT3) expression. High-salt diet (HSD)-induced Dahl salt-sensitive rats hypertensive renal injury led to decreased SIRT3 expression and an increase in EMT and oxidative stress. In contrast, Cana administration rescued SIRT3 expression, decreased both EMT and levels of oxidative stress, and ameliorated renal injury. Furthermore, we compared the antihypertensive and renoprotective properties of Cana when combined with irbesartan (Irb), a renin-angiotensin system (RAS) blocker. We concluded that administration of Cana in combination with Irb had a significantly greater effect in lowering systolic blood pressure when compared to Cana monotherapy. However, no statistical differences were observed between combined therapy and monotherapy groups with regards to the lowering of diastolic blood pressure and renoprotection. Utilizing the human renal proximal tubular epithelial cell line (HK-2), Angiotensin II (AngⅡ) induced HK-2 negatively regulated the expression of SIRT3, FOXO3a, catalase, and promoted EMT, all of which were reversed by Cana. Furthermore, SIRT3 silencing abolished Cana-mediated rescue of forkhead box O3a (FOXO3a) and catalase expression and Cana-mediated suppression of EMT in AngⅡ induced HK-2. Taken together, Cana acts as a renoprotective agent by suppressing EMT in the pathology of renal fibrosis via interaction with the SIRT3-FOXO3a pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionKidney DiseasesSirtuin 3AnimalsHumansRatsCanagliflozinCatalaseDietEpithelial-Mesenchymal TransitionFibrosisIrbesartanKidneyOxidative StressRats, Inbred DahlSodium Chloride, DietarySirtuins

Stichwörter der Autor:innen

CanagliflozinEpithelial-mesenchymal transitionHigh-salt dietHypertensionKidneySGLT2 inhibitors

Substanzen

CanagliflozinCatalaseIrbesartanSirtuin 3Sodium Chloride, DietarySIRT3 protein, ratSirtuinsSIRT3 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; Department of Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; Department of Geriatric Cardiology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Department of Geriatric Cardiology, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Department of Internal Medicine, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Department of Cardiology, The Third Hospital of Shijiazhuang City Affiliated to Hebei Medical University, Shijiazhuang, Hebei, China.

Förderung

  • Hebei University of Science and Technology

Zitieren

APA

Wang, Z., Zhai, J., Zhang, T., He, L., Ma, S., Zuo, Q., Zhang, G., Wang, Y., & Guo, Y. (2023). Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress. Biochemical and Biophysical Research Communications, 653, 53-61. https://doi.org/10.1016/j.bbrc.2023.01.084

Vancouver

Wang Z, Zhai J, Zhang T, He L, Ma S, Zuo Q, et al. Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress. Biochemical and Biophysical Research Communications. 2023;653:53-61. doi:10.1016/j.bbrc.2023.01.084

BibTeX
@article{Wang2023,
  author = {Wang, Zhongli and Zhai, Jianlong and Zhang, Tingting and He, Lili and Ma, Sai and Zuo, Qingjuan and Zhang, Guorui and Wang, Yan and Guo, Yifang},
  title = {Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {653},
  pages = {53--61},
  doi = {10.1016/j.bbrc.2023.01.084}
}
Kostenlos starten →